Maroon Biotech has two primary goals: provide pharmaceutical and industrial manufacturers with high quality research-grade polymers and develop our surfactant chaperone technology for research and industrial applications.
First, even high-quality commercially available polymers present challenges to researchers and manufacturers. Materials such as poloxamers and polyethylene glycol, which are commonly used in pharmaceutical and cosmetic products, are highly susceptible to degradation and often contain cytotoxic byproducts and stabilizers. Maroon has developed an efficient method for purifying these compounds to provide higher quality starting materials to our vendors. Read more about what sets our products apart here.
One such compound is a symmetric block copolymers of polyethylene oxide-polypropylene oxide-polyethylene oxide (PEO-PPO-PEO), which has been used to reduce blood viscosity for more than fifty years. However, its capability of membrane repair was unknown until the late 1980’s when Raphael C. Lee, MD, ScD, DSc, Professor of Molecular Medicine and Surgery at the University of Chicago Pritzker School of Medicine, discovered its unique cell membrane healing properties. This exciting discovery led to the founding of Maroon Biotech and our company’s second objective: the development of our surfactant chaperone technology.
Maroon’s surfactant chaperones are developed based on the same advanced, high-quality polymers we provide to our customers, and have the capability to restore structure and viability to cells disrupted by physical and chemical trauma. By reversing post-traumatic molecular alterations, Maroon Biotech’s product promises to improve recovery from severe traumatic injuries, electrical shock, and reperfusion injury. The technology has already demonstrated efficacy in treating experimental spinal cord injury, myocardial infarction, and brain injury. Maroon is also applying its technology to industrial protein processing, which will enable the company to broaden its industry scope. More information on our research and product development can be found here.
Maroon Biotech is actively engaged in contract research and open to collaboration in areas relating to membrane function which supports the development of our core technologies.